BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8219264)

  • 1. No decreased erythrocyte deformability in type 1 (insulin-dependent) diabetes, either by filtration or by ektacytometry.
    Schut NH; van Arkel EC; Hardeman MR; Bilo HJ; Michels RP; Vreeken J
    Acta Diabetol; 1993; 30(2):89-92. PubMed ID: 8219264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood and plasma viscosity in diabetes: possible contribution to late organ complications?
    Schut NH; van Arkel EC; Hardeman MR; Bilo HJ; Michels RP; Vreeken J
    Diabetes Res; 1992 Jan; 19(1):31-5. PubMed ID: 1468184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of erythrocyte deformability by filtration rate.
    Mataseje A; Beder I; Kittova M; Okkelova J; Vazan R
    Bratisl Lek Listy; 2003; 104(4-5):158-60. PubMed ID: 14604257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the effect of poorly controlled diabetes mellitus on erythrocyte life.
    Sayinalp S; Sözen T; Usman A; Dündar S
    J Diabetes Complications; 1995; 9(3):190-3. PubMed ID: 7548984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus.
    Shin S; Ku YH; Ho JX; Kim YK; Suh JS; Singh M
    Clin Hemorheol Microcirc; 2007; 36(3):253-61. PubMed ID: 17361027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diabetic control and biosynthetic human insulin on blood rheology in established diabetics.
    Leiper JM; Lowe GD; Anderson J; Burns P; Cohen HN; Manderson WG; Forbes CD; Barbenel JC; MacCuish AC
    Diabetes Res; 1984 May; 1(1):27-30. PubMed ID: 6397284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of reduced red blood cell deformability and diabetic nephropathy.
    Brown CD; Ghali HS; Zhao Z; Thomas LL; Friedman EA
    Kidney Int; 2005 Jan; 67(1):295-300. PubMed ID: 15610255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte adhesion to cultured endothelium and glycaemic control in type 1 (insulin-dependent) diabetic patients.
    Wautier JL; LeBlanc H; Wautier MP; Abadie E; Passa P; Caen JP
    Diabetologia; 1986 Mar; 29(3):151-5. PubMed ID: 3516772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidation of spectrin and deformability defects in diabetic erythrocytes.
    Schwartz RS; Madsen JW; Rybicki AC; Nagel RL
    Diabetes; 1991 Jun; 40(6):701-8. PubMed ID: 2040386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorheological Approach for Early Detection of Chronic Kidney Disease and Diabetic Nephropathy in Type 2 Diabetes.
    Lee S; Lee MY; Nam JS; Kang S; Park JS; Shin S; Ahn CW; Kim KR
    Diabetes Technol Ther; 2015 Nov; 17(11):808-15. PubMed ID: 26214546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of metabolic equilibrium on erythrocyte deformability in diabetes mellitus].
    Stufano N; Sabbà C; Altomare E; Perna MT; Berardi E; Vendemiale G; Albano O
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1853-8. PubMed ID: 6518097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of red cell deformability by a filtration method in type 1 and type 2 diabetes mellitus with and without vascular complications.
    MacRury SM; Small M; Anderson J; MacCuish AC; Lowe GD
    Diabetes Res; 1990 Feb; 13(2):61-5. PubMed ID: 2091871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of diabetic or obese patients' erythrocyte deformability by the program of the brain-oriented obesity control system (BOOCS).
    Saito K; Odashiro K; Maruyama T; Akashi K; Mawatari S; Fujino T
    J Physiol Sci; 2012 Nov; 62(6):445-51. PubMed ID: 22843251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration.
    Chiarelli F; Cipollone F; Romano F; Tumini S; Costantini F; di Ricco L; Pomilio M; Pierdomenico SD; Marini M; Cuccurullo F; Mezzetti A
    Diabetes; 2000 Jul; 49(7):1258-63. PubMed ID: 10909986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood rheology and cardiovascular risk factors in type 1 diabetes: relationship with microalbuminuria.
    Jay RH; Jones SL; Hill CE; Richmond W; Viberti GC; Rampling MW; Betteridge DJ
    Diabet Med; 1991; 8(7):662-7. PubMed ID: 1833119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition.
    Garnier M; Attali JR; Valensi P; Delatour-Hanss E; Gaudey F; Koutsouris D
    Metabolism; 1990 Aug; 39(8):794-8. PubMed ID: 2377077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte deformability and its variation in diabetes mellitus.
    Shin S; Ku Y; Babu N; Singh M
    Indian J Exp Biol; 2007 Jan; 45(1):121-8. PubMed ID: 17249336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior long term glycaemic control and insulin therapy in insulin-dependent diabetic adolescents with microalbuminuria.
    Kalk WJ; Osler C; Taylor D; Panz VR
    Diabetes Res Clin Pract; 1990 Apr; 9(1):83-8. PubMed ID: 2190783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.